Join the club for FREE to access the whole archive and other member benefits.

Amir Zarrinpar

Gastroenterologist Assistant Professor of Medicine

As the health burden of obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) increases, Amir Zarrinpar hopes to perform high-impact research investigating novel therapeutic pathways in these diseases that, as of yet, have few curative options.

He is a physician scientist who performs basic, translational, and clinical research focused on diseases related to metabolism (e.g. metabolic syndrome, obesity, non-alcoholic fatty liver disease, atherosclerosis, and type 2 diabetes. His laboratory investigates the intersection of circadian rhythms, gut signaling, and the microbiome and how the three together can underlie a variety of pathological conditions. By using engineered bacteria and time restricted feeding, we hope to understand how to prevent and treat these conditions. He is also a practicing gastroenterologist at VA San Diego where he directs the bariatric endoscopy clinic and perform research investigating how to use precision medicine to improve weight loss and non-alcoholic liver disease outcomes. Finally, he is a dedicated mentor, striving to help young scientists achieve their career goals. 

Visit website: https://providers.ucsd.edu/details/22338/gastroenterology

 amir-zarrinpar-95158271

See also: Academia UC San Diego School of Medicine - School for medical and scientific training.

Details last updated 16-Aug-2022

Mentioned in this Resource

Amir Zarrinpar News

Employing native bacteria as ideal chassis for therapeutic delivery and cure

Employing native bacteria as ideal chassis for therapeutic delivery and cure

UC San Diego School of Medicine - 04-Aug-2022

Re-engineered native bacteria serve as chassis to introduce therapeutics into the gut